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Abstract  
ArnT is a glycosyltransferase that catalyses the addition of 4-amino-4-deoxy-L-arabinose (L-
Ara4N) to the lipid A moiety of the lipopolysaccharide. This is a critical modification enabling 
bacteria to resist killing by antimicrobial peptides. ArnT is an integral inner membrane protein 
consisting of 13 predicted transmembrane helices and a large periplasmic C-terminal domain. 
We report here the identification of a functional motif with a canonical consensus sequence 
DEXRYAX(5)MX(3)GXWX(9)YFEKPX(4)W spanning the first periplasmic loop, which is highly 
conserved in all ArnT proteins examined. Site-directed mutagenesis demonstrated the 
contribution of this motif in ArnT function, suggesting that these proteins have a common 
mechanism. We also demonstrate that the Burkholderia cenocepacia and Salmonella enterica 
serovar Typhimurium ArnT C-terminal domain is required for polymyxin B resistance in vivo. 
Deletion of the C-terminal domain in B. cenocepacia ArnT   resulted in a protein with 
significantly reduced in vitro binding to a lipid A fluorescent substrate and unable to catalyse 
lipid A modification with L-Ara4N. An in silico predicted structural model of ArnT strongly 
resembled the tertiary structure of Campylobacter lari PglB, a bacterial oligosaccharyltransferase 
involved in protein N-glycosylation. Therefore, distantly related oligosaccharyltransferases from 
ArnT and PglB families operating on lipid and polypeptide substrates, respectively, share 
unexpected structural similarity that could not be predicted from direct amino acid sequence 
comparisons. We propose that lipid A and protein glycosylation enzymes share a conserved 
catalytic mechanism despite their evolutionary divergence.	
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Introduction  
The lipopolysaccharide (LPS) resides on the outer leaflet of the Gram-negative bacterial outer 
membrane and consists of three distinct structural regions: O antigen, core oligosaccharide, and 
lipid A. Both O antigen and core are made of covalently linked sugars, whereas lipid A has fatty 
acids bonded to a glucosamine disaccharide, which is embedded in the outer membrane (Nikaido 
2003).  Lipid A is the major signaling component of LPS and elicits innate immune responses 
ranging from mild inflammation to lethal sepsis (Miller, et al. 2005, Mogensen 2009). The lipid 
A backbone structure is highly conserved in most bacteria, but it is also remodelled by the 
addition or subtraction of components in response to environmental cues (Needham and Trent 
2013). For example, covalent modification of phosphate groups in the lipid A by the addition of 
positively charged moieties, such as phosphoethanolamine (Kim, et al. 2006, Raetz, et al. 2007), 
galactosamine (Wang, et al. 2009), glucosamine (Marr, et al. 2008) and 4-amino-4-deoxy-L-
arabinose (L-Ara4N) (Molinaro, et al. 2015, Trent, et al. 2001), reduce the overall negative 
charge of the molecule. These covalent modifications confer resistance to cationic antimicrobial 
peptides such as polymyxin B (PmB) and aminoglycoside antibiotics, and are associated with 
enhanced bacterial virulence (Needham and Trent 2013).  
 Burkholderia cenocepacia is an opportunistic pathogen infecting immune compromised 
individuals (Mahenthiralingam, et al. 2008, Vandamme and Dawyndt 2011), especially those 
with cystic fibrosis. The modification of lipid A of B. cenocepacia with L-Ara4N is constitutive 
and essential for B. cenocepacia cell viability (Ortega, et al. 2007), as L-Ara4N-modified lipid A 
is required for LPS export to the outer membrane (Hamad, et al. 2012, Ortega, et al. 2007). 
Further, L-Ara4N ligation to lipid A confers PmB resistance to B. cenocepacia and other bacteria 
such as Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, Bordetella 
bronchiseptica, Yersinia enterocolitica, Yersinia pestis, and Proteus mirabilis (Boll, et al. 1994, 
Ernst, et al. 1999, Gunn, et al. 1998, Guo, et al. 1997, Kaca, et al. 1990, Loutet and Valvano 
2011, Rolin, et al. 2014). 
 L-Ara4N is formed as an undecaprenyl-phosphate (Und-P)-linked precursor that is 
translocated across the plasma membrane and subsequently transferred to lipid A by ArnT 
(Raetz, et al. 2007) (Figure 1). ArnT is an integral membrane protein that belongs to the 
glycosyltransferase C superfamily (GT-C) (Liu and Mushegian 2003). The GT-C family proteins 
utilize Und-P-linked sugar substrates (Lairson, et al. 2008) and consists of proteins characterized 
by multiple transmembrane helices, a large periplasmic loop close to the N-terminus, and an 
extended C-terminal domain also located in the periplasm (Igura, et al. 2008, Korkegian, et al. 
2014, Kus, et al. 2008, Lizak, et al. 2011, Maeda, et al. 2001, Strahl-Bolsinger, et al. 1993, 
Tavares-Carreon, et al. 2015). The precise mechanism of lipid A glycosylation with L-Ara4N by 
ArnT is unknown, but the structural information on the anomeric nature of the Und-P-α-L-Ara4N 
donor (Trent, et al. 2001) and the β configuration of the L-Ara4N linkage to the lipid A 
phosphates (Zhou, et al. 2000) suggests that ArnT is an inverting glycosyltransferase. It is 
however unclear how ArnT recognizes Und-P-L-Ara4N and lipid A and which amino acid 
residues are involved in the ligation reaction. Conceivably, residues exposed to the periplasm are 
involved in the ligation of L-Ara4N to the lipid A phosphate groups. This may occur either by a 
direct role in catalysis or binding to both donor (Und-P-L-Ara4N) and acceptor (lipid A) 
molecules, as it has been observed for other glycosyltransferases that carry similar reactions such 
as the E. coli WaaL (Boll, et al. 1994, Perez, et al. 2008), Campylobacter PglB (Kowarik, et al. 
2006, Lizak, et al. 2011), Shigella flexneri GtrIV protein of (Nair, et al. 2011), and Emb enzymes 
of Mycobacterium tuberculosis (Belanger, et al. 1996, Telenti, et al. 1997). Agreeing with this 
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notion, we have previously identified four conserved periplasmic residues predicted to be 
required for ArnT catalysis (Tavares-Carreon, et al. 2015). These four residues, corresponding to 
tyrosine-43, lysine-69, arginine-254, and glutamic acid-493 (according to the B. cenocepacia 
ArnT protein), reside at conserved positions and are required for the activity of both B. 
cenocepacia and S. enterica ArnT proteins (Tavares-Carreon, et al. 2015).  
 In this work, we identify a signature motif, DEXRYAX(5)MX(3)GXWX(9)YFEKPX(4)W (the 
tyrosine-43 and lysine-69 residues are underlined) , which is highly conserved in all members of 
the ArnT protein family and resides in the first periplasmic loop; this signature motif includes the 
residues that were previously found to be required for ArnT activity (Tavares-Carreon, et al. 
2015). We also characterized the large ArnT C-terminal domain and show that sequential 
deletions of this domain result in B. cenocepacia and S. enterica ArnT proteins that could not 
restore PmB resistance in ΔarnT mutant strains. Importantly, we show that the ArnT C-terminal 
domain is required for lipid A binding, explaining why this region may be needed for ArnT 
function. Further, we show by molecular modelling that ArnT has similar predicted structural 
conformation as the bacterial N-oligosaccharyltransferase PglB (Lizak, et al. 2011), suggesting 
that that protein and lipid oligosaccharyltransferases of two distantly related protein families 
share common structural features. 
 
Results 
ArnT proteins share a functional motif that defines the members of this family 
ArnT is classified within GT-C superfamily, particularly the GT83 glycosyltransferase family of 
the CAZy database (carbohydrates-active enzymes) (Lombard, et al. 2014). The GT-C 
superfamily includes large hydrophobic proteins with eight to thirteen predicted transmembrane 
helices. ArnT primary sequences from B. cenocepacia and S. enterica share an overall sequence 
identity of 29% and a similarity of 64.5% (Figure 2). Both proteins consist of two domains, an 
N-terminal transmembrane domain spanning approximately 437 residues, which is composed by 
13 transmembrane helices, and a large soluble C-terminal domain, including the remaining 121 
amino acids, oriented towards the periplasm (Tavares-Carreon, et al. 2015). GT-C family 
members have a modified DXD signature (conserved in glycosyltransferases) corresponding to 
EXD, DXE, DDX or DEX (Liu and Mushegian 2003).  We identified a 39DEX41 motif in ArnT 
sequence from B. cenocepacia and S. enterica (Figure 2, dashed-lined box). To determine 
whether the DEX motif is necessary for the activity of B. cenocepacia ArnT, we replaced the 
aspartic acid and glutamic acid residues by alanine, and assessed the abilities of mutant proteins 
to restore PmB resistance in the B. cenocepacia ∆arnT-arnBC+lptGD31H suppressor strain MH55 
(Table 1) (herein ∆arnT). This strain is highly sensitive to PmB, but viable due to a suppressor 
mutation that rescues export of lipid A-core to the outer membrane (Hamad, et al. 2012). Alanine 
replacements are commonly used to identify the functional relevance of predicted conserved 
aspartates in DXD motifs of many glycosyltransferases (Birch, et al. 2009, Breton and Imberty 
1999, Korkegian, et al. 2014, Korres and Verma 2006, Liu and Mushegian 2003, Maeda, et al. 
2001, Perrin-Tricaud, et al. 2011, Ramiscal, et al. 2010). We observed that B. cenocepacia 
ArnTD39A could not restore PmB resistance when expressed in ∆arnT (Figure 3A), similar to the 
negative control only containing the cloning vector (Figure 3A, pSCrhaB2). In contrast, 
ArnTE40A remained functional since expression of this protein restored PmB resistance at a 
similar level as that the wild-type strain (Figure 3A). The alanine replacement mutant proteins 
were detected in the membrane fraction by immunoblotting and they were expressed at wild type 
levels (Figure 3B). The corresponding residues in S. enterica ArnT, aspartic acid-32 and 
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glutamic acid-33, were also investigated. The Salmonella ArnTSe-FLAG-10xHis fusion resulted in a 
protein that could not complement E. coli ∆arnT strain, likely due to structural constrains 
associated with a proline at the C-terminal end of the protein (Bretscher, et al. 2006). This was 
resolved by replacing proline-547 by alanine, which did not alter ArnT function (Tavares-
Carreon, et al. 2015). Therefore, the alanine replacements in aspartic acid-32 and glutamic acid-
33 were made in the P547A ArnTSe-FLAG-10xHis protein. Both residues were required for function 
since the respective alanine substituted proteins could not restore PmB resistance in the E. coli 
∆arnT strain (Figure 3C). Therefore, depending of the source of the ArnT proteins one or both 
residues in the DEX motif are required for function.  
 The functional data for B. cenocepacia ∆arnT were consistent with the chemical structure of 
the B. cenocepacia lipid A, as examined by mass spectrometry using matrix-assisted laser 
desorption/ionization-time of flight (MALDI-TOF) in the negative ion mode. The mass spectrum 
of the wild-type lipid A sample showed the presence of L-Ara4N, as indicated by ion peaks 
corresponding to tetra-acylated lipid A with L-Ara4N in the monophosphate (at m/z 1495.3) and 
diphosphate (at m/z 1575.3) forms (Figure 3D) in agreement with the reported B. cenocepacia 
lipid A structure (Hamad, et al. 2012, Silipo, et al. 2005, Tavares-Carreon, et al. 2015). These ion 
peaks were absent in the lipid A spectrum of ∆arnT alone and ∆arnT expressing ArnTD39A 
(Figure 3E-F), while ion peaks containing L-Ara4N were restored in the lipid A sample from 
∆arnT containing ArnTE40A (Figure 3G). These results indicate that the aspartic acid-39 in the 
DEX motif is critical for B. cenocepacia ArnT function.  
 Multiple sequence alignments of ArnT proteins from different bacteria were compared with 
our topology prediction data to identify transmembrane segments and loops regions. Previously, 
we reported two identifiable motifs, 42RYA44 and 66YFEKP70, in which residues tyrosine-43 and 
lysine-69 were found to be necessary for ArnT function (Tavares-Carreon, et al. 2015). Also, a 
conserved tryptophan residue is present at position 75 (Tavares-Carreon, et al. 2015). All of 
these motifs including the DEX motif examined here reside in the first periplasmic loop of ArnT. 
We hypothesized that the three motifs 39DEX41, 42RYA44, 66YFEKP70, and W75 form a larger 
motif unique to ArnT protein family members (Figure 4A). The fingerprint sequence 
39DEXRYAX(5)MX(3)GXWX(9)YFEKPX(4)W75, where X represent a variable but usually 
hydrophobic amino acid, was used to search the Swiss-Prot and TrEMBL databases with the 
ScanProsite tool (http://prosite.expasy.org/scanprosite/) resulting in 1,133 hits that corresponded 
to proteins putatively annotated as ArnT. From these 1,119 sequences were from different 
species of Proteobacteria, and the others were from Actinobacteria (5 sequences), Enterococcus 
gallinarum (1 sequence), and various uncultured bacteria and hits from metagenomic projects (8 
sequences). An alignment using a subset of these proteins highlights the strong conservation of 
this motif (Figure 4A), which was also validated by a search using Weblogo server (Crooks, et 
al. 2004) (Figure 4B). Together, these results reveal a conserved signature motif in first 
periplasmic loop of ArnT that also contains functional residues and is unique to both functionally 
characterized and predicted ArnT proteins. 
 
The C-terminal domain of ArnT is required for function 
Alignment of the C-terminal domain of ArnT proteins showed that this portion of the protein is 
the least conserved in primary amino acid sequence. However, secondary structure predictions 
reveal strong similarities between the C-terminal domains of B. cenocepacia and S. enterica 
ArnT proteins with a conserved predicted α/β structure (Figure 2). To investigate the role of the 
periplasmic C-terminal region on ArnT function, we created a series of constructs encoding 
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derivatives of B. cenocepacia ArnT with sequential C-terminal deletions. These deletions were 
designed to gradually remove the terminal domain (ArnT∆10, ArnT∆40, ArnT∆80, and ArnT∆CT) 
(Figure 2). The functionality of the truncated proteins was assessed in vivo by determining their 
ability to restore PmB resistance in B. cenocepacia ∆arnT. To facilitate detection of ArnT, all 
these proteins also had a C-terminal FLAG-10xHis epitope. The incorporation of the double-
epitope in the wild type ArnT does not interfere with the functionality of the enzyme, as judged 
by the full complementation of PmB resistance in ∆arnT expressing ArnTFLAG-10xHis (Figure 5A) 
(Tavares-Carreon, et al. 2015). However, all C-terminal truncations failed to restore PmB 
resistance in ∆arnT, including the shortest truncation (ArnT∆10) (Figure 5A).   
 To investigate the basis of the PmB-sensitive phenotype of the C-terminal truncation strains, 
we first determined if the mutant proteins were localized in membranes. Membrane fractions 
from these strains were analysed by immunoblot. ArnTWT migrated as a 66.3-kDa polypeptide, 
while ArnT∆10, ArnT∆40, ArnT∆80, and ArnT∆CT migrated as 64.9, 61.6, 56.8 and 52.3 kDa 
polypeptides, respectively (Figure 5B). These polypeptides were detectable in the membrane 
fraction indicating that the mutant proteins are localized in the membrane. Therefore, the 
functional defect of ArnT truncations is not due to membrane mislocalization. 
 We next investigated the effect of the C-terminal truncations on lipid A modification with L-
Ara4N using MALDI-TOF mass spectrometry. The mass spectrum from the wild-type sample 
revealed the presence of L-Ara4N in the monophosphate and diphosphate forms (Figure 6A), 
which was absent in the ∆arnT lipid A spectrum (Figure 6B). Mass spectrometry analysis of lipid 
A from ∆arnT carrying ArnT∆10, ArnT∆40, ArnT∆80, and ArnT∆CT did not reveal any peaks 
corresponding to glycoforms containing L-Ara4N (Figure 6C-F). These results agree with the 
hypersensitivity to PmB of the strain expressing these truncated proteins (Figure 5A), confirming 
the C-terminal domain of ArnT is necessary for the lipid A modification by L-Ara4N. 
 We next asked whether deletion of the C-terminal domain of S. enterica ArnT (herein 
ArnTSe) is functionally important. Two constructions were made resulting in the deletion of the 
complete C-terminal domain or the last 10 amino acids of ArnTSe. The ArnTSe functionality was 
assayed by complementation of PmB resistance in the E. coli ∆arnT mutant (Tavares-Carreon, et 
al. 2015). The results indicated that none of these proteins restored PmB resistance, suggesting 
that the last 10 amino acids are also required for the S. enterica ArnT activity (Figure 7A). 
Immunoblot analysis of membrane fractions revealed a band migrating below the 63-kDa mass 
standard, which agrees with the predicted molecular mass for ArnTSe of 59-kDa. We could detect 
ArnTSe∆10 and ArnTSe∆CT as polypeptides with apparent masses of 57 and 47 kDa, respectively 
(Figure 7B). These results indicated that similar to ArnTBc, the truncation of the ArnTSe C-
terminus results in a protein that is localized to the membrane but unable to confer PmB 
resistance, strongly suggesting that despite the differences in primary amino acid sequence, the 
C-terminal domain in both ArnT proteins is required for function. 
 
An in silico structural model of ArnT resembles the crystal structure of the PglB 
oligosaccharyltransferase 
To gain further insight about the ArnT structure we generated an in silico structural model of B. 
cenocepacia ArnT using I-Tasser (Roy, et al. 2010). Remarkably, among the best templates in 
the database automatically used by I-Tasser to generate the ArnT model, we found the crystal 
structure of the oligosaccharyltransferase PglB from	Campylobacter lari (PDB entry: 3RCE) 
(Lizak, et al. 2011). Therefore, we refined the predicted ArnT model using the tertiary structure 
of PglB as the template. Structural comparison between PglB with the predicted ArnT model (I-
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Tasser C-score of -0.59) revealed that despite their low sequence identity (~24%) both proteins 
share strong structural homology (Figure 8). The resulting tridimensional model of ArnT 
exhibited a similar architecture as PglB consisting primarily of two domains: an N terminal 
domain containing transmembrane helices connected by short loops and a hydrophilic C-terminal 
domain with a globular conformation. The predicted structural model of ArnT was supported by 
our previous topological results that identified ArnT residues by substituted cysteine scanning 
mutagenesis (Tavares-Carreon, et al. 2015). Further, examination of the C-terminal region 
reveals that the last 10 residues required for ArnT activity (Figure 5A) form a predicted anti-
parallel β-sandwich structure, which is also present in PglB (Figure 8A-B). The β-sandwich 
contains mostly hydrophobic and some charged amino acid residues. To better characterize this 
region in ArnT we introduced alanine replacements in conserved and charged residues (Figure 
9A). Alanine replacement of arginine-549, glutamic acid-554 and lysine-555 residues did not 
affect ArnT function, as determined by complementation of PmB resistance in B. cenocepacia 
∆arnT (Figure 9B). However, alanine substitution of hydrophobic amino acids such as 
isoleucine-544 and a double mutant valine-551/isoleucine-552 resulted in proteins that could not 
restore PmB resistance (Figure 9C). To eliminate the possibility that the double epitope (FLAG-
10xHis) located at the C-terminus could interfere with ArnT function, we introduced a stop 
codon before the FLAG-10xHis tag coding sequence in the double alanine replacement mutant 
valine-551/isoleucine-552. The ArnTV551A/I552A protein lacking the FLAG-10xHis epitope could 
not restore PmB resistance when expressed in ∆arnT (Figure 9C). The same result was obtained 
using the identical mutant protein containing FLAG-10xHis demonstrating that the C-terminal 
double tag was not involved in the phenotype observed for the double mutant V551-I552. The 
alanine replacement mutant in ArnTV551A-I552A was expressed at wild type levels and it appeared 
in the membrane fraction (Figure 9D).  The predicted ArnT tridimensional structural model 
shows that isoleucine-544, valine-551, and isoleucine-552 face each other (Figure 8B). Thus, we 
propose that these residues are required for the overall structural stability of ArnT or proper 
folding of the C-terminal domain.  
 
The C-terminal domain of ArnT is required for LPS binding 
Elucidation of the tertiary structure of C. lari PglB revealed that both the transmembrane and the 
soluble periplasmic domains participate in substrate binding and catalysis (Lizak, et al. 2011). 
Also, the	C-terminal part was found to pin the acceptor peptide to the active site in the X-ray 
structure (Lizak, et al. 2011). Based on structural comparison between the predicted ArnT model 
and the PglB structure we hypothesized that the pocket in ArnT that is comparable to the PglB 
peptide binding pocket is involved in binding the lipid A instead of a peptide. This region in the 
predicted ArnT model is the only one that has a pocket of a diameter such that could 
accommodate the lipid A molecule. To explore this hypothesis, we performed an in vitro binding 
assay using purified ArnT proteins and a resin-capture procedure previously described (Sestito, 
et al. 2014). ArnT was immobilized on the Ni2+-NTA resin and then Alexa-conjugated LPS from 
S. enterica Serovar Minnesota was added. The Alexa-LPS-ArnT complex was eluted from resin 
and the fluorescence was measured. In contrast to parental ArnT, ArnT∆10 showed at least a 3-
fold decrease in binding and virtually no binding was observed in ArnT∆CT (Figure 10A). 
However, the purified isolated C-terminal domain failed to bind LPS (Figure 10A), suggesting 
that the C-terminal domain alone is not sufficient for LPS binding. The levels of truncated 
protein were detected by immunoblotting (Figure 10B), indicating that all of them were 
expressed at wild type levels. 
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 The reduction in the LPS binding for ArnT∆CT and ArnT∆10 could also reflect structural 
modifications imposed by the C-terminal truncations. We employed a direct approach using 
substituted cysteine accessibility by methoxypolyethylene glycol maleimide (PEG-mal) labelling 
to assess the ArnT topology in the mutant proteins. PEG-mal is a membrane-impermeable 
maleimide with a mass ~5 kDa that results in a clear size-shift of the label protein, which can be 
detected by immunoblot. PEG-mal modification using EDTA-permeabilized whole cells 
indicates that the cysteine has a periplasmic orientation. While PEG-mal modification under 
denaturing conditions (presence of SDS) suggests that the cysteine is within a transmembrane 
helix or faces the cytoplasm. We constructed cysteine replacements in asparagine-62, lysine-69, 
phenylalanine-247 and arginine-254; these residues are positioned in the periplasmic loops 1 and 
2, respectively (Tavares-Carreon, et al. 2015). The cysteine replacement mutants were made in a 
cysteineless version of ArnT with the corresponding C-terminal deletion. PEGylation assays 
using the resulting proteins showed PEG-mal labelling of ArnTN62C, ArnTK69C, ArnTF247C, and 
ArnTR254C under non-denaturing conditions (Figure 10C). This indicated that these residues are 
exposed to the periplasmic face as previously established (Tavares-Carreon, et al. 2015), 
demonstrating that the C-terminal deletions did not cause gross changes in the conformation of 
the membrane domain of ArnT. 
 
Discussion 
Glycosyltransferases catalyse the synthesis of glycoconjugates by transferring an activated 
sugar residue to an appropriate acceptor molecule. Most glycosyltransferases possess a DXD 
signature, which is typically found in the enzymes utilizing nucleotide-activated sugars as donor 
substrates (Ramakrishnan, et al. 2004). It is proposed that the negatively charged aspartic acid 
residues in the DXD motif and the phosphate group of the nucleotide group are held together by 
a divalent metal ion (Lairson, et al. 2008, Liu and Mushegian 2003, Wiggins and Munro 1998). 
A similar function could be envisaged for the DXD motif in ArnT and the phosphate group of 
Und-P-Ara4N. The GT-C glycosyltransferases proteins to which ArnT belongs present a relaxed 
version of the DXD motif. We show here that this relaxed motif is part of a larger periplasmic 
signature motif, DEXRYAX(5)MX(3)GXWX(9)YFEKPX(4)W, which is highly conserved in ArnT 
proteins from diverse proteobacterial species. Alanine replacement of the aspartic acid-39 
residue in B. cenocepacia ArnT (aspartic acid-32 in S. enterica ArnT) resulted in a non-
functional protein that lost the ability to modify lipid A with L-Ara4N. The functional 
importance of the aspartic acid in the DEX motif was established for several glycosyltransferases 
including the human PIG-M protein (Maeda, et al. 2001), Mycobacterium smegmatis 
PimE/EmbC proteins (Korkegian, et al. 2014, Morita, et al. 2006), and Pyrococcus furiosus 
AglB protein (Matsumoto, et al. 2013), underscoring the requirement for acidic residues in the 
active site GT-C glycosyltransferases, as previously suggested (Franco and Rigden 2003). 
However, the alanine replacement of the glutamic acid present in the DEX motif resulted in a 
non-functional S. enterica ArnT but did not affect the B. cenocepacia protein. The reasons for 
this difference are presently unclear.   
 Our previous work suggested that the ArnT C-terminal domain residing on the periplasm 
plays a role in ArnT function (Tavares-Carreon, et al. 2015), as expected for an enzyme using 
substrates only accessible in the periplasm (Raetz, et al. 2007, Trent, et al. 2001). However, the 
precise function of the C-terminal domain has not been investigated. We show here that that the 
last ten amino acids were required for the ability of ArnT in B. cenocepacia and S. enterica to 
modify lipid A with L-Ara4N and to confer PmB resistance. In silico modelling of ArnT 
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predicted that a structure that closely resembles that of oligosaccharyltransferases involved in 
protein N-glycosylation. In eukaryotes, protein N-glycosylation requires a multiprotein 
membrane complex (Knauer and Lehle 1999), from which STT3 is the catalytic subunit (Yan 
and Lennarz 2002). STT3 is homologous to the prokaryotic PglB and AglB proteins, which also 
catalyse N-glycosylation reactions (Feldman, et al. 2005, Igura, et al. 2008, Kelleher and 
Gilmore 2006, Knauer and Lehle 1999). ArnT, PglB, AglB and STT3 could not be aligned due to 
their very low sequence homology. However, remarkable similarities where found by comparing 
the established tri-dimensional structures of PglB and AlgB with an in silico ArnT structural 
model. Most notably, these enzymes show a transmembrane domain including a relatively large 
periplasmic loop, and a C-terminal globular domain exposed to the periplasmic space. 
Comparison between the tridimensional predicted structure of the C-terminal soluble domain of 
B. cenocepacia and the solved structure of the globular C-terminal domain of PglB, 
Mycobacterium tuberculosis EmbC, Pyrococcus furiosus AglB, and Archaeoglobus fulgidus 
AglB-S1 (Alderwick, et al. 2011, Igura, et al. 2008, Maita, et al. 2010, Matsumoto, et al. 2012) 
showed conserved features. These domains present a globular conformation mainly by α-helical 
domain surrounded by β-strands. The C-terminal region has been demonstrated as the peptide 
substrate binding domain for PglB, EmbC, Corynebacterium glutamicum RptA and A. fulgidus 
AglB-Long (Birch, et al. 2009, Korkegian, et al. 2014, Lizak, et al. , Matsumoto, et al. 2013). 
Remarkably, our in vitro binding assay reveals for the first time that the C-terminal domain of 
ArnT is involved in lipid A substrate binding. Thus, we propose that the C-terminal domain of 
ArnT is the lipid A binding domain. However, the isolated C-terminal domain of ArnT expressed 
without the transmembrane region was unable to bind lipid A, a finding also observed with the 
isolated C-terminal domain in N-glycosylation proteins, which is unable to bind the acceptor 
peptide (Korkegian, et al. 2014, Maita, et al. 2010, Matsumoto, et al. 2012), indicating that C-
terminal domain is not sufficient for substrate binding. Substrate binding in these enzymes may 
require the transmembrane region, especially one or more periplasmic loops. We also found that 
the two β-strands located in the last ten amino acids of the C-terminal domain of ArnT are 
functionally important, likely by contributing to the structural integrity of the C-terminal fold. 
Comparison of the modelled C-terminal domain of ArnT with the solved structures C-terminal 
domain of P. furiosus AglB and C. lari PglB proteins also reveal β-strands-like folding which 
are structurally or functionally essential for these proteins (Igura, et al. 2008, Maita, et al. 2010).  
 The discovery of a new signature motif and a similar feature of the C-terminal domain in 
ArnT with the distantly related oligosaccharyltransferases PglB and AlgB, highlights a common 
fold architecture for these enzymes irrespective of the protein or lipid nature of their specific 
substrates. We speculate that the bacterial and eukaryotic glycosyltransferases with similar 
functions may have evolved in parallel or may be derived from an ancient common ancestor, 
either by gene exchanges between organisms or by convergent evolution. Collectively, our 
results strongly suggest that the predicted tertiary structure of ArnT share properties in common 
to the solved structures of bacterial N-glycosylation oligosaccharyltransferases, revealing an 
unexpected conservation of evolutionary divergent enzymes that glycosylate proteins and lipids 
in the extracytoplasmic compartment.  
 
Materials and methods 
Bacterial strains and growth conditions 
Bacterial strains and plasmids are listed in Table I. Growth medium was supplemented as needed 
with the following chemicals (final concentrations): ampicillin (100 µg ml-1), trimethoprim (100 
9	
	
µg ml-1), gentamicin (25 µg ml-1), PmB (10 µg ml-1), L-arabinose 0.2%; w/v), and L-rhamnose 
(0.2%; w/v). Bacteria were grown aerobically at 37 °C in Luria-Bertani (LB) medium (Difco). 
For recombinant protein expression, bacteria were grown overnight in 5 mL of LB, diluted to 
A600 of 0.1, and incubated at 37°C for 2 h until cultures reached A600 of 0.5, at which point L-
arabinose or L-rhamnose was added and cells incubated for 3 h at 37°C. 
 
DNA methods and plasmid construction  
Plasmid pFT1 encoding the B. cenocepacia arnTFLAG-10xHis was used as template (Tavares-
Carreon, et al. 2015). Gene deletions eliminating 10, 40, 80, and 121 amino acid residues from 
the ArnT C-terminus (ArnT∆10, ArnT∆40, ArnT∆80, and ArnT∆CT, respectively) were constructed 
by PCR amplification using the forward primer 6269 containing an EcoRI restriction site, which 
anneals upstream of the arnT coding sequence, and the reverse primers 6424, 6425, 6426, and 
6739 that anneal downstream of arnT and contain a SalI restriction site. PCR products were 
digested with EcoRI and SalI and ligated into pFT1 also digested with the same enzymes. 
 pFT143 encoding the S. enterica arnTSe-FLAG-10xHis gene (Tavares-Carreon, et al. 2015) was 
used as a template to delete the whole C-terminal domain of ArnT (with 6475 and 7296 primers), 
and the last 10 C-terminal residues (with 6475 and 7295). PRC products were digested with 
EcoRI and SalI and ligated into the same sites in pFT143. Novel amino acid codons for amino 
acid replacements in both ArnT proteins were introduced in the respective genes by PCR using 
primers containing the desired mutations, pFT1 or pFT143 as templates, and the Pfu Turbo AD 
polymerase (Agilent Technologies). Upon completion PCR reactions were incubated with DpnI 
overnight at 37°C to digest parental plasmid DNA. The resulting DNA was introduced into E. 
coli DH5α by CaCl2 transformation. Plasmids were sequenced with primers 252, 258 and 6385 
for B. cenocepacia arnT or 7179 for S. enterica arnT (Table II) to confirm the presence of the 
desired mutations. For the cloning of the C-terminal domain of B. cenocepacia arnT, primers 
7380 and 6270 with NcoI and SalI restriction sites respectively were used for a PCR reaction. 
The amplicon was digested with NcoI and SalI and ligated into pFT1 equally digested, giving 
rise to pFT232. 
 
Complementation of ArnT function in B. cenocepacia  
Genes expressing the ArnT replacement mutant proteins were subcloned into the NdeI-HindIII 
site of pSCrhaB2, and the recombinant constructs introduced into the PmB-sensitive ∆arnT-
arnBC+ lptGD31H (∆arnT) suppressor strain by triparental mating (Craig, et al. 1989, Figurski and 
Helinski 1979). The ability of each construct to restore PmB resistance to wild type levels 
denoted ArnT function. Strains were grown overnight with 0.4% (w/v) rhamnose (to induce 
protein expression), diluted to 10-1, 10-2, 10-3, 10-4 and 10-5 and 4 µl of each dilution plated onto 
LB plates supplemented with 0.4% rhamnose and 10 µg ml-1 PmB. 
 
Membrane preparation and immunoblotting 
Bacterial pellets were resuspended in 50 mM Tris-HCl, pH 8.0, with protease inhibitors and 
lysed at 10, 000 PSI using a cell disruptor (Constant Systems, Kennesaw, GA). Cell debris was 
pelleted by centrifugation at 15,000 × g for 15 min at 4°C, and the clear supernatant was 
centrifuged at 40,000 × g for 30min at 4°C. The pellet containing total membranes was 
suspended 50 mM Tris-HCl, pH 8.0. Protein concentration was determined by the Bradford 
assay (Bio-Rad). Proteins were separated by SDS-PAGE on a 12% gel and transferred to a 
nitrocellulose membrane. Immunoblots were probed with anti-FLAG (Sigma) mouse monoclonal 
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antibodies. Secondary anti- mouse Alexa fluor-680 IgG antibody (Invitrogen) was used to detect 
fluorescence using an Odyssey infrared imaging system (LI-COR Biosciences). 
 
Lipid A isolation and mass spectrometry 
Lipid A ʟ-Ara4N modifications were identified by mass spectrometry (MS) analysis using 
matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF). Cells were grown 
overnight in LB medium (100 ml) supplemented with 50 µg/ml trimethoprim and 0.4 % 
rhamnose. Cultures were centrifuged (10,000 × g), washed twice with phosphate buffer (10 mM 
Na2HPO4, 1.7 mM KH2PO4) and freeze-dried. Lipid A was extracted from lyophilized cells and 
desalted as previously described (El Hamidi, et al. 2005). Ten milligrams of the lyophilized 
bacterial cells were resuspended in 400 µl of a mixture of isobutyric acid: 1 M Ammonium 
hydroxide (5:3, v/v) and were kept for 2 h at 100°C with vortexing every 15 min., then 
centrifuged at 2000 × g for 15 min and the supernatant was mixed with an equal volume of water 
and lyophilized. The sample was washed with methanol twice and then lipid A was solubilized in 
80 µl of chloroform: methanol: water (3:1.5:0.25, v/v). Lipid A suspension was desalted with a 
few grains of ion-exchange resin (Dowex 50W-X8; H+). 2 µl aliquot of desalted lipid A 
suspension was loaded on polished steel target, air dried and covered by 1 µl of 2,5-
dihydroxybenzoic acid matrix (DHB) (Sigma Chemical) dissolved in 0.1 M citric acid aqueous 
solution and allowed to dry. The target was inserted in a Bruker Autoflex MALDI-TOF 
spectrometer. Data acquisition and analysis were performed using the Flex Analysis software. 
 
Expression and purification of ArnT 
ArnTFLAG-10xHis, ArnTΔCT-FLAG-10xHis, ArnTΔ10-FLAG-10xHis and C-terminal domain-FLAG-10xHis 
recombinant proteins were purified as previously reported (Ruan and Valvano 2013). Proteins 
were overexpressed in E. coli DH5α cells in a 1 litre of LB. Cells were grown to A600 of 0.6 at 
37°C and induced with 0.2% (w/v) arabinose for 4 h. Cells were harvested by centrifugation and 
pellets were stored at -20°C before membrane preparation. All subsequent steps were carried out 
at 4°C. Membrane preparation was solubilized in Equilibration buffer (50 mM phosphate buffer 
pH 8.0, 150 mM NaCl, 10% (v/v) glycerol, and 1% (w/v) N-dodecyl-β-D-maltopyranoside 
(Sigma-Aldrich) for 4 h. All purification buffers contained N-dodecyl-β-D-maltopyranoside. 
ArnT was purified from membranes on a nickel-nitrilotriacetic acid affinity column. The column 
was washed twice in Equilibration buffer with 50 mM of imidazole and the protein was eluted 
with Equilibration buffer containing 250 mM imidazole. Elution fractions were monitored by 
12% polyacrylamide SDS-PAGE. The pooled fractions containing purified protein were dialyzed 
twice against 200 volumes of Equilibration buffer and finally concentrated in a Vivaspin 15R 
column (10, 000 molecular weight cut off, Sartorious). Protein concentration was determined by 
Bradford assay with bovine serum albumin as standard.  
 
LPS binding by resin capture method 
The in vitro LPS binding assay was based on a previous protocol with a few modifications 
(Sestito, et al. 2014). Briefly, purified ArnT protein (200 µg) was incubated in 0.5 ml of 
Phosphate/NaCl buffer (50 mM phosphate buffer pH 8.0, 150 mM NaCl) with 0.06 ml of 
HisLink protein purification resin (Promega) for 90 min on a rotary shaker at 4 °C. Unbound 
protein was removed by decanting the resin-bound ArnT. Resin-bound was incubated in 0.5 ml 
of Phosphate/NaCl buffer and 10 µg of Alexa-LPS conjugated from Salmonella serovar 
Minnesota (Molecular Probes) at room temperature in the dark on rotary shaking for further 90 
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min. The resin was washed twice with 0.5 ml of Phosphate/NaCl buffer. The protein-LPS 
complex was eluted with 0.5 ml of Phosphate/NaCl buffer containing 300 mM imidazole. The 
eluted (0.5 ml) was divided in 100 µl and placed in a Microplate, white flat-bottomed (Greiner 
bio-one) and fluorescence was measured in a Fluoroskan Ascent FL Microplate Fluorometer 
(Thermo Labsystems) (λex=485nm, λem=527). 
 
Sulfhydryl labelling 
Plasmids containing ArnTFLAG-10xHis cysteine substitutions with ΔC-terminal or Δ10 amino acids 
deletions were introduced into E. coli DH5α by CaCl2 transformation. Cultures were grown and 
sulfhydryl labelling was performed as previously described (Tavares-Carreon, et al. 2015). 
Briefly, cell pellets were resuspended in 0.3 ml of HEPES/MgCl2 buffer and divided in three 
portions: 0.1 ml of cell suspension was incubated with 1 mM methoxypolyethylene glycol 
maleimide (PEG-Mal) at room temperature for 1 h with 50 mM EDTA; 0.1 ml was treated with 
2% SDS prior to labelling, and 0.1 ml was incubated with buffer as control. The reaction was 
stopped with 45 mM of dithiothreitol for 10 min and mixed with 3X dye buffer (50 mM Tris-
HCl [pH 6.8], 2% SDS, 10% glycerol, and 0.1% Bromophenol blue), and incubated for 30 min at 
45°C. Mild denaturation conditions were used to optimize ArnT detection, as these conditions 
work best for membrane proteins (Ruan and Valvano 2013). 
 
Bioinformatics and in silico modelling of ArnT 
Homology searches were performed with BLASTP and PSI-BLAST. Alignments of amino acid 
sequences were performed by ClustalW (Chenna, et al. 2003). ArnT was classified within GT83 
glycosyltransferase family using the CAZy database (carbohydrate-active enzymes) 
(www.cazy.org) (Lombard, et al. 2014). Graphical representation of the signature motif in ArnT 
homologues were made by Weblogo (http://weblogo.berkeley.edu) (Crooks, et al. 2004). Motif 
search was done on the Swiss-Prot and TrEMBL databases using the ScanProsite tool (de Castro, 
et al. 2006). A fasta file containing all the sequences obtained from this analysis is available from 
the authors upon request. For in silico modelling the B. cenocepacia ArnT amino acid sequence 
was submitted to the I-TASSER server with default parameters (Roy, et al. 2010). Figures were 
prepared with the PyMOL molecular graphics system, version 1.7.2.3 (Schrödinger, LLC, 
Portland, OR).  
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Supplementary Figures S1 and S2. 
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TABLE I. Strains and plasmids used in this study. 
Strain or Plasmids Relevant Properties Source or Reference 
Strains   
E. coli   
DH5α F- φ80lacZM15 endA recA hsdR(r-Κ m-Κ) supE 
thi gyrA relA Δ(lacZYA-argF)U169 
Laboratory stock 
∆arnT BL21(DE3) ΔarnT (Impellitteri, et al. 2010)  
   
B. cenocepacia   
K56-2 Parental strain, clinical isolate of the ET12 
clone  
BCRRCa  
(Mahenthiralingam, et al. 
2000)  
MH55  ∆arnT-arnBC+ lptGD31H  (Hamad, et al. 2012)  
   
Plasmids   
pBAD24 Expression vector inducible with arabinose, 
for C-terminal FLAG-10xHis fusions, ApR 
(Guzman, et al. 1995)  
pMH494 pSCrhaB2-arnTSe Hamad and Valvano, in 
preparation. 
pRK2013 Helper plasmid used for bacterial conjugation; 
KmR 
(Figurski and Helinski 
1979)  
pSCrhaB2 Expression vector inducible with rhamnose. 
Broad host range replicative vector; TpR 
(Cardona and Valvano 
2005)  
pFT1 pBAD expressing ArnTFLAG-10xHis  (Tavares-Carreon, et al. 
2015)  
pFT3 pSCrhaB2, ArnTFLAG-10xHis (Tavares-Carreon, et al. 
2015) 
pFT9 pFT1, ArnT∆CT This study 
pFT10 pFT1, ArnT∆80 This study 
pFT11 pFT1, ArnT∆40 This study 
pFT32 pFT1, ArnT∆10 This study 
pFT17 pFT3, ArnT∆CT This study 
pFT18 pFT3, ArnT∆80 This study 
pFT19 pFT3, ArnT∆40 This study 
pFT35 pFT3, ArnT∆10 This study 
pFT124 pFT1, ArnTE554A This study 
pFT129 pFT3, ArnTE554A This study 
pFT143 pBAD, ArnTSe-P547A-FLAG-10xHis (Tavares-Carreon, et al. 
2015) 
pFT147 pFT1, ArnTR549A This study 
pFT148 pFT1, ArnTK555A This study 
pFT151 pFT3, ArnTR549A This study 
pFT152 pFT3, ArnTK555A This study 
pFT165 pFT1, ArnTD39A This study 
pFT166 pFT1, ArnTE40A This study 
pFT167 pFT3, ArnTD39A This study 
pFT168 pFT3, ArnTE40A This study 
pFT169 pFT143, ArnTSe-D32A This study 
pFT170 pFT143, ArnTSe-E33A This study 
pFT175 pBAD, ArnTSe∆CT This study 
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pFT176 pBAD, ArnTSe∆10 This study 
pFT177 pFT1, ArnTV551A-I552A This study 
pFT179 pFT3, ArnTV551A-I552A This study 
pFT193 pFT1, ArnTI544A This study 
pFT194 pFT3, ArnTI544A This study 
pFT222 pFT1, ArnTV551A-I552A-STOP This study 
pFT223 pFT3, ArnTV551A-I552A-STOP This study 
pFT224 pFT38, ArnTN62C∆CT This study 
pFT225 pFT77, ArnTK69C∆CT This study 
pFT226 pFT79, ArnTF247C∆CT This study 
pFT227 pFT55, ArnTR254C∆CT This study 
pFT228 pFT38, ArnTN62C∆10 This study 
pFT229 pFT77, ArnTK69C∆10 This study 
pFT230 pFT79, ArnTF247C∆10 This study 
pFT231 pFT55, ArnTR254C∆10 This study 
pFT232 C-terminal domain of ArnTFLAG-10xHis This study 
aB. cepacia Research and Referral Repository for Canadian CF Clinics. 
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TABLE II. Primers used in this study. 
Primer DNA Sequence Restriction 
site 
Purpose 
252 5'-GATTAGCGGATCCTACCTGA None pBAD24 forward 
258 5'-GACCGCTTCTGCGTTCTGAT None pBAD24 reverse 
6269 5'-aaagaattcATGAACGATACGCCGTCGAGGC EcoRI ArnTBc  forward 
6270 5'-aaagtcgactcCGATTGCGGTTTCTCGACGATC SalI ArnTBc reverse 
6385 5'-CAGCGCAACCCCGAGTTCTTCAAC None ArnTBc, internal primer 
6424 5'-	aaagtcgactcCCCGGTGCCGCCGATCGTGCC SalI ArnTBc∆CT reverse 
6425 5'-	aaagtcgactcCGGGAACGTGTGGTCGAGCAT SalI ArnTBc∆80 reverse 
6426 5'-	aaagtcgactcCTGCTTCCAGCGCGTGATCCA SalI ArnTBc∆40 reverse 
6475 5'-aaagaattcATGAAATCGATACGCTATTATC EcoRI ArnTSe forward 
6739 5'-	aaagtcgactcGTTGTCGCGCGCGATCACGCG SalI ArnTBc∆10 reverse 
7179 5'- GTGGTTGTCCTTCCCTGGGCGATCG None ArnTSe, internal primer 
7295 5'-	aaagtcgactcCCCCTGATAATCAATATTGTC SalI ArnTSe∆10 reverse 
7296 5'-	aaagtcgactcGGGGATGGAAAAGCCGAACAG SalI ArnTSe∆CT reverse 
7380 5'-aaaaccatgggcGACGAGTTCGGCCGCTACAGC NcoI ArnTBc forward 
Restriction sites are underlined. 
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Figures 
 
Fig 1.  Diagram illustrating the synthesis and incorporation of 4-amino-4-deoxy-L-arabinose (L-
Ara4N) into the lipid A. Soluble UDP-glucuronic acid is converted to Und-P-α-L-Ara4N by the 
cytoplasmic proteins ArnA, ArnB, ArnC, and ArnD on the cytoplasmic face on the inner 
membrane (Raetz, et al. 2007). The flippase ArnE/ArnF transports Und-P-α-L-Ara4N to the 
periplasmic face of the inner membrane. The lipid A-core is exported to the periplasmic face of 
the inner membrane by the MsbA flippase. The integral membrane protein ArnT transfers the L-
Ara4N moiety to the lipid A-core.  
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Fig 2. Comparison of the predicted secondary structure of B. cenocepacia and S. enterica ArnT 
proteins. Alignment showing identical amino acids in dark grey boxes. Asterisks indicate the 
DEX motif. Dashed-line box indicates the amino acids corresponding to the signature motif at 
the first periplasmic loop of ArnT family protein. The secondary structure was predicted with 
PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/); filled bars and arrows indicate α-helices and β-
strands, respectively. The filled triangles below the sequences indicate the endpoint of 
truncations of the ArnT C-terminal domain.  
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Fig 3. The DEX motif is relevant for ArnT function. (A) The functionality of ArnTBc proteins 
with alanine replacements in the charged amino acid residues of the DEX motif was assessed 
using B. cenocepacia ∆arnT-arnBC+ strain MH55 (Table 1) (∆arnT). Bacteria containing pFT3 
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expressing ArnTFLAG-10xHis (ArnTWT) or the cloning vector pSCrhaB2 were used as positive and 
negative controls, respectively. Bacteria were spotted on LB plates with 0.4% rhamnose (to 
allow for protein expression) or 0.4% rhamnose plus PmB 10 µg ml-1. (B) Total membrane 
preparation from ∆arnT. Ten µg of protein was analysed by SDS-PAGE, and the immunoblot 
was probed with the antibody anti-FLAG. L, BLUeye prestained protein ladder (C) The 
functionality of ArnTSe proteins alanine replacements in the DEX motif was assessed in E. coli 
∆arnT. Bacteria expressing ArnTSeP547A-FLAG-10xHis (ArnTP547A) or the cloning vector pBAD24 
were used as a positive control and negative controls, respectively. ArnTP547A is a modified 
ArnTSe that has an alanine instead of a proline at the C-terminal end of the protein, which does 
not affect function but makes the protein detectable by immunoblotting (Tavares-Carreon, et al. 
2015). WT, indicates the parental E. coli BL21(DE3) containing pBAD24. Bacteria were spotted 
on LB plate with 0.2% arabinose (to allow for protein expression) or 0.2% arabinose plus PmB 
2.5 µg ml-1. (D-G) MALDI-TOF spectra obtained using the negative ion mode of purified lipid 
A produced by ∆arnT alone and ∆arnT expressing ArnTBc (WT), ArnTD39A, and ArnTE40A. The 
profiles represented were tetra-acylated lipid A with 1 or 2 phosphates molecules, tetra-acylated 
lipid A with 1 L-Ara4N and 1 or 2 phosphate molecules, penta-acylated lipid A, and penta-
acylated lipid A with L-Ara4N and 2 phosphates. 
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Fig 4. Conserved signature motif in ArnT family members. (A) CLUSTAL W multiple sequence 
alignment of a subset of bacterial ArnT homologues, which were identified from a scan prosite 
search using the B. cenocepacia ArnT protein as a query, as described in Results and in Materials 
and Methods. Alignments were determined with the program CLUSTAL W. The figure shows a 
partial alignment of the region spanning the periplasmic loop 1 located between transmembrane 
domains I and II (indicated with grey bars). Amino acids depicted with a dark grey background 
and asterisks denote identical residues across the proteins examined. Green and red asterisks 
indicate residues studied in this work and in a previous study, respectively (Tavares-Carreon, et 
al. 2015).  Conserved residues are marked in light grey. The sequences from the following 
organisms were compared: B. cenocepacia, B. multivorans, B. dolosa, B. pseudomallei, S. 
enterica, E. coli, Pseudomonas aeruginosa, P. mandelii, P. fluorescens, Proteus mirabilis, 
Yersinia pestis, Shigella flexneri, Serratia marcescens, Ralstonia solanacearum, R. picketii, 
Klebsiella pneumoniae, K. oxytoca, Citrobacter freundii, Aeromonas hydrophila, Erwinia 
mallotivora, Enterobacter aerogenes, Edwarsiella piscicida, Cupriavidus basilensis, C. necator. 
(B) Weblogo illustrating the conserved DEXRYAX(5)MX(3)GXWX(9)YFEKPX(4)W signature 
motif in the ArnT family. 
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Fig 5. The C-terminal domain of B. cenocepacia ArnT is required for function. (A) 
Complementation of the ∆arnT-arnBC+lptGD31H (∆arnT; MH55, Table 1) suppressor strain 
transformed with pSCrhaB2 encoding, ArnT∆10, ArnT∆40, ArnT∆80, and ArnT∆CT. Cells 
expressing ArnTFLAG-10xHis and the vector pSCrhaB2 were used as positive (WT) and negative 
controls, respectively. The transformants were spotted on LB supplemented with 0.4% of L-
rhamnose and 10 µg ml-1 of PmB. (B) Immunoblot of total membranes from ∆arnT expressing 
ArnTFLAG-10xHis, ArnT∆10, ArnT∆40, ArnT∆80, and ArnT∆CT performed with anti-FLAG. L, 
BLUeye prestained protein ladder. 
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Fig 6. Structural analysis of purified lipid A. MALDI-TOF spectra of purified lipid A produced 
by the ∆arnT suppressor strain transformed with plasmids encoding ArnT wild-type, ArnT∆10, 
ArnT∆40, ArnT∆80, or ArnT∆CT. The profiles represented were obtained using the negative ion 
mode.  
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Fig 7. The C-terminal domain is also required for the function of S. enterica ArnT. (A) 
Complementation of E. coli ∆arnT with ArnTSe∆10 and ArnTSe∆CT. pFT143 expressing ArnTP547A 
was used as a positive control.  The cloning vector pBAD24 was used as a negative control. WT, 
indicates the parental E. coli BL21(DE3) containing pBAD24. Bacteria were spotted on LB 
plates with 0.2% arabinose or 0.2% arabinose plus PmB 2.5 µg ml-1. (B) Total protein from cells 
expressing ArnTSe∆10 and ArnTSe∆CT proteins were separated by SDS-PAGE and detected with 
antibody anti-FLAG. L, BLUeye prestained protein ladder. 
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Fig 8. The ArnT predicted tertiary structure resembles the structure of the PglB protein. (A) In 
silico model of B. cenocepacia ArnT generated by the I-Tasser server. Two views of the 
structure related by 180° rotation are shown. The last β-strands of the C-terminal domain are 
indicated in green, the signature motif for the ArnT family in red, and the functional residues 
Y43, K69, I544, V551, and I552 in blue. (B) Close-up of residues I544, V551, and I552 located 
in the last β-strands of the C-terminal domain of ArnT. (C) Solved structure of PglB from C. lari 
(PDB accession number 3RCE) and cavities located in opposite sides of PglB indicated the 
catalytic side and the peptide binding. 
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Fig 9. Hydrophobic residues located in the last β-sandwich structure contribute to the overall 
structure of ArnT. (A) Schematic representation of the primary and secondary structure of the 
last twenty-three amino acids of the C-terminal domain of ArnT. Arrows indicate β-strands and 
the residues replaced by alanine are underlined. (B-C) Functional analysis of alanine 
replacements in charged or hydrophobic amino acid residues by complementation of ∆arnT 
(strain MH55, Table 1). ArnTFLAG-10xHis and pSCrhaB2 were used as positive and negative 
control, respectively. Rham, 0.4% rhamnose; PmB, 0.4% rhamnose plus polymyxin B 10 µg ml-
1. V551A-I552A has a double epitope at the C-terminal whereas V551A-I552A* does not 
express the FLAG-10xHis double tag. (D) Immunoblot of total membranes preparation from 
∆arnT containing plasmids expressing ArnTWT and ArnTV551A-I552A . Ten µg of protein was 
separated by SDS-PAGE, and the immunoblot was probed with the antibody anti-FLAG. L, 
BLUeye prestained protein ladder. 
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Fig 10. The C-terminal domain of ArnT is involved in the Lipid A binding. (A) Quantification of 
the LPS binding assay, 200 µg of each purified protein were incubated with 10 µg of Alexa-LPS 
at room temperature. Fluorescence signal was normalized to the buffer alone. Binding of LPS to 
the resin alone as a control. Values represent the mean of four independent experiments.  (B) 
ArnTWT, ArnT∆10, ArnT∆CT and C-terminal domain purified proteins were separated by SDS-
PAGE 16% and detected with antibody anti-FLAG. The high-mass oligomeric forms of each 
result from the mild denaturation conditions used to visualize ArnT. L, BLUeye prestained 
protein ladder. (C)  PEG-mal labelling of periplasmic amino acids in ArnT∆10 (∆10) or ArnT∆CT 
(∆CT). E. coli DH5α cells carrying plasmids encoding ArnT cysteine replacements with the 
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respectively C-terminal were harvested and resuspended in HEPES/MgCl2 buffer. 0.1 ml of cell 
suspension was incubated with buffer alone or 1 mM PEG-mal with or without 2% SDS for 1 h 
at room temperature. Immunoblot was performed with anti-FLAG antibodies. L, BLUeye 
prestained protein ladder.  
 
